Clinical Trial Detail

NCT ID NCT02299635
Title A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch Alterations
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Pfizer
Indications

triple-receptor negative breast cancer

Therapies

PF-03084014

Age Groups: adult

No variant requirements are available.